Finance

Lists
SGRY:NASDAQ
Surgery Partners Inc
13,89 USD
+1,83%
(+0,25) 1D
13,89 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGRY...
Open
13,69 USD
High
14,06 USD
Low
13,60 USD
Mkt. cap
1,82 млд
Avg. vol.
2,25 млн
Volume
929,01 миң
52-wk high
23,44 USD
52-wk low
11,41 USD
EPS
-0,69 USD
Beta
1,91
Shares outstanding
130,92 млн
No. of employees
16 миң
Open
13,69 USD
High
14,06 USD
Low
13,60 USD
Mkt. cap
1,82 млд
Avg. vol.
2,25 млн
Volume
929,01 миң
52-wk high
23,44 USD
52-wk low
11,41 USD
EPS
-0,69 USD
Beta
1,91
Shares outstanding
130,92 млн
No. of employees
16 миң
News stories
From web sources and news partners
About Surgery Partners Inc
CEO-
Employees16 миң
Founded2004
Headquarters-
SectorHealth care provider
Websitesurgerypartners.com
Analyst ratings
Based on 9 analysts giving stock ratings to SGRY in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SGRY in the last 3 months.
Highest
Current 13,89 USD
24,00 USD (+72,79%)
Average
18,50 USD (+33,19%)
Lowest
14,00 USD (+0,79%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Hold
Maintained
14,00 USD
+0,8%
10/07/2026
Ben Hendrix
RBC Capital
Buy
Maintained
19,00 USD
+36,8%
09/29/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
20,00 USD
+44%
09/18/2026
Ryan Langston
TD Cowen
Buy
Reiterated
19,00 USD
+36,8%
09/18/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
15,00 USD
+8%
09/14/2026
Bill Sutherland
StoneX
Buy
Reiterated
24,00 USD
+72,8%
08/11/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
18,00 USD
+29,6%
08/10/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/11/2026
Gary Taylor
TD Cowen
Buy
Reiterated
19,00 USD
+36,8%
08/11/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
19,00 USD
+36,8%
07/13/2026
Brian Tanquilut
Jefferies
Buy
Maintained
17,00 USD
+22,4%
05/06/2026
A.J. Rice
UBS
Buy
Maintained
21,00 USD
+51,2%
03/10/2026
Last report
2026-ж., 10-авг.
Fiscal period
Q2 2026
0,10 USD / 0,06 USD
+59,57%beat
Revenue / Est. (USD)
848,90 млн / 830,32 млн
+2,24%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
821,50 млн
885,00 млн
810,90 млн
848,90 млн
Cost of goods sold
626,20 млн
672,80 млн
650,70 млн
658,70 млн
Cost of revenue
626,20 млн
672,80 млн
650,70 млн
658,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,40 млн
23,70 млн
39,30 млн
36,30 млн
Operating expense
60,20 млн
78,70 млн
76,10 млн
73,70 млн
Total operating expenses
686,40 млн
751,50 млн
726,80 млн
732,40 млн
Operating income
135,10 млн
133,50 млн
84,10 млн
116,50 млн
Other non operating income
1,60 млн
8,10 млн
-
1,40 млн
EBT including unusual items
30,80 млн
42,60 млн
-3,30 млн
32,30 млн
EBT excluding unusual items
65,40 млн
72,50 млн
19,10 млн
53,10 млн
Income tax expense
5,50 млн
13,60 млн
-1,20 млн
2,60 млн
Effective tax rate
17,86%
31,92%
36,36%
8,05%
Other operating expenses
-1,70 млн
-4,90 млн
-1,70 млн
-1,90 млн
Net income
-22,70 млн
-15,00 млн
-35,90 млн
-15,00 млн
Net profit margin
-2,76%
-1,69%
-4,43%
-1,77%
Earnings per share
0,13
0,12
-0,03
0,10
Interest and investment income
-
-
-
-
Interest expense
-76,50 млн
-75,70 млн
-69,10 млн
-71,20 млн
Net interest expenses
-76,50 млн
-75,70 млн
-69,10 млн
-71,20 млн
Depreciation and amortization charges
39,50 млн
59,90 млн
38,50 млн
39,30 млн
EBITDA
174,60 млн
193,40 млн
122,60 млн
155,80 млн
Gain or loss from assets sale
15,60 млн
11,40 млн
4,30 млн
2,40 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору